Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Food and Drug Administration (FDA)
Biotech
FDA reveals 2nd round of 'national priority' voucher winners
The program is designed to cut the agency's typical 10- to 12-month review timeline down to just one or two months.
Darren Incorvaia
Nov 6, 2025 3:12pm
FDA puts Intellia CRISPR trials on hold over raised liver enzyme
Oct 30, 2025 6:37am
Former FDA deputy to guide Charles River animal testing strategy
Oct 15, 2025 10:00am
Denali's Hunter syndrome drug latest to be hit by FDA delay
Oct 14, 2025 8:09am
Former FDA official Peter Marks joins Eli Lilly
Oct 7, 2025 3:49pm
Rocket aborts mission to get rare disease gene therapy approved
Oct 3, 2025 9:30am
